Skip to main content
. 2022 Apr 13;14(8):1951. doi: 10.3390/cancers14081951

Figure 2.

Figure 2

Mutations in “other genes” in MTC patients. The type and distribution of mutations affecting other genes different from RET and RAS is shown. Each column represents a specific patient, and the presence of the indicated mutations is indicated by a blue tag. Only genes mutated in at least two patients are shown. (A) Patients lacking RET/RAS mutations (n = 30) were assigned to the group “other genes”; patients with mutations in other genes not identified in at least two patients were assigned to the group “other genes unique”. (B) Patients with concurrent RET/RAS mutations (n = 58). (C) Genes mutated only in patients reported in (B). * indicates nonsense mutations.